407 related articles for article (PubMed ID: 34198859)
21. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Bauzon M; Hermiston TW
Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
[TBL] [Abstract][Full Text] [Related]
22. Considerations for Clinical Translation of MG1 Maraba Virus.
Breitbach CJ
Methods Mol Biol; 2020; 2058():285-293. PubMed ID: 31486046
[TBL] [Abstract][Full Text] [Related]
23. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC; Kirn D
Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
[TBL] [Abstract][Full Text] [Related]
25. Virotherapy Research in Germany: From Engineering to Translation.
Ungerechts G; Engeland CE; Buchholz CJ; Eberle J; Fechner H; Geletneky K; Holm PS; Kreppel F; Kühnel F; Lang KS; Leber MF; Marchini A; Moehler M; Mühlebach MD; Rommelaere J; Springfeld C; Lauer UM; Nettelbeck DM
Hum Gene Ther; 2017 Oct; 28(10):800-819. PubMed ID: 28870120
[TBL] [Abstract][Full Text] [Related]
26. Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.
Kennedy BE; Sadek M; Gujar SA
Mol Ther; 2020 Jun; 28(6):1417-1421. PubMed ID: 32243836
[TBL] [Abstract][Full Text] [Related]
27. Tumor Targeting of Oncolytic Adenoviruses Using Bispecific Adapter Proteins.
Niemann J; Kühnel F
Methods Mol Biol; 2020; 2058():31-49. PubMed ID: 31486030
[TBL] [Abstract][Full Text] [Related]
28. Synergistic interaction between oncolytic viruses augments tumor killing.
Le Boeuf F; Diallo JS; McCart JA; Thorne S; Falls T; Stanford M; Kanji F; Auer R; Brown CW; Lichty BD; Parato K; Atkins H; Kirn D; Bell JC
Mol Ther; 2010 May; 18(5):888-95. PubMed ID: 20234341
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic herpes simplex virus engineering and preparation.
Agarwalla PK; Aghi MK
Methods Mol Biol; 2012; 797():1-19. PubMed ID: 21948465
[TBL] [Abstract][Full Text] [Related]
30. Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Nettelbeck DM; Leber MF; Altomonte J; Angelova A; Beil J; Berchtold S; Delic M; Eberle J; Ehrhardt A; Engeland CE; Fechner H; Geletneky K; Goepfert K; Holm PS; Kochanek S; Kreppel F; Krutzke L; Kühnel F; Lang KS; Marchini A; Moehler M; Mühlebach MD; Naumann U; Nawroth R; Nüesch J; Rommelaere J; Lauer UM; Ungerechts G
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452286
[TBL] [Abstract][Full Text] [Related]
31. Employing tumor hypoxia for oncolytic therapy in breast cancer.
Chun YS; Adusumilli PS; Fong Y
J Mammary Gland Biol Neoplasia; 2005 Oct; 10(4):311-8. PubMed ID: 16826462
[TBL] [Abstract][Full Text] [Related]
32. Attenuated oncolytic measles virus strains as cancer therapeutics.
Msaouel P; Iankov ID; Dispenzieri A; Galanis E
Curr Pharm Biotechnol; 2012 Jul; 13(9):1732-41. PubMed ID: 21740361
[TBL] [Abstract][Full Text] [Related]
33. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
34. Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5' RNA genome end methodology.
Israelsson S; Sävneby A; Ekström JO; Jonsson N; Edman K; Lindberg AM
Invest New Drugs; 2014 Dec; 32(6):1063-70. PubMed ID: 25052234
[TBL] [Abstract][Full Text] [Related]
35. Naturally oncolytic viruses.
Roberts MS; Lorence RM; Groene WS; Bamat MK
Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic viruses targeting tumor stem cells.
Chiocca EA; Blair D; Mufson RA
Cancer Res; 2014 Jul; 74(13):3396-8. PubMed ID: 24753541
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
[TBL] [Abstract][Full Text] [Related]
38. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy.
Lal G; Rajala MS
Cancer Gene Ther; 2018 Oct; 25(9-10):216-226. PubMed ID: 29735993
[TBL] [Abstract][Full Text] [Related]
39. Regulatory aspects of oncolytic virus products.
Yamaguchi T; Uchida E
Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in oncolytic virus-based cancer therapy.
Fu LQ; Wang SB; Cai MH; Wang XJ; Chen JY; Tong XM; Chen XY; Mou XZ
Virus Res; 2019 Sep; 270():197675. PubMed ID: 31351879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
